Dr.Datsons Labs

DR.DATSONSLABS21 May 2015

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Dr.Datsons Labs

Dr.Datsons Labs

Pharmaceuticals

DR.DATSONSLABS21 May 2015

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
30-May-2013	D	Aanjaneya Lifecare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has : 1. Recommended a Dividend, subject to the approval of shareholders in the ensuing Annual General Meeting of the Company @ 1.00 % on 1,38,87,151 Equity Shares of the Rs. 10/- each (i.e. Rs. 0.10/- (Ten Paise) per Equity Share) to the concerned shareholders as on Record Date.	20-Sep-2013
30-May-2012	D	Aanjaneya Lifecare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, has recommended a Dividend, subject to the approval of shareholders in the ensuing Annual General Meeting of the Company @ 20% on 1,38,87,151 Equity Shares of the Rs. 10/- each (i.e. Rs. 2/- per Equity Share).	31-Aug-2012
04-Mar-2021	BC	(As Per NSE Circular Dated on 04.03.2021)	05-Mar-2021
12-Feb-2020	BC	Trading Members of the Exchange are hereby informed that the undermentioned 28 suspended companies at the Exchange have been delisted by NSE. In view thereof in terms of Rule 21(2)(b) of the Securiti	14-Feb-2020
15-Jun-2018	BC	Sub : Delisting In terms of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 ('Regulations'), Section 21A of the Securities Contract (Regulations) Act, 1956	02-Jul-2018
12-Jun-2015	BC	Dr.Datsons Labs Ltd has informed BSE that the following changes in Directorship of the Company have taken place: 1. The Change in designation of Mr. Rajendra Kamat, as a Non Executive Director o	25-May-2015
18-May-2015	BC	Sub:- Suspension of Trading in the Equity Shares of Dr.Datsons Labs Ltd and S. Kumars Nationwide Limited. Trading members are hereby informed that the following companies are under Liquidation f	22-May-2015

No Rights has been declared by DR.DATSONSLABS

Book Closure

Record Date	Split Date	Purpose
05-Mar-2021	-	(As Per NSE Circular Dated on 04.03.2021)
14-Feb-2020	-	Trading Members of the Exchange are hereby informed that the undermentioned 28 suspended companies at the Exchange have been delisted by NSE. In view thereof in terms of Rule 21(2)(b) of the Securiti
02-Jul-2018	-	Sub : Delisting In terms of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 ('Regulations'), Section 21A of the Securities Contract (Regulations) Act, 1956
25-May-2015	-	Dr.Datsons Labs Ltd has informed BSE that the following changes in Directorship of the Company have taken place: 1. The Change in designation of Mr. Rajendra Kamat, as a Non Executive Director o
22-May-2015	-	Sub:- Suspension of Trading in the Equity Shares of Dr.Datsons Labs Ltd and S. Kumars Nationwide Limited. Trading members are hereby informed that the following companies are under Liquidation f

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Dr.Datsons Labs Ltd ₹6.40(0.00/0.00%)	6.40	+0.00	70.13	-65.78	0.00	0.11
Lupin Ltd ₹1,654.75(+7.10/0.43%)	1,654.75	+7.10	75,415.25	133.18	36.60	3.91
Ipca Laboratories Ltd ₹1,337.70(-13.30/-0.98%)	1,337.70	-13.30	33,938.01	88.94	61.57	5.46
J B Chemicals & Pharmaceuticals Ltd ₹1,889.90(+4.30/0.23%)	1,889.90	+4.30	29,330.27	80.31	57.90	10.92
Sanofi India Ltd ₹8,624.25(-53.50/-0.62%)	8,624.25	-53.50	19,861.65	59.17	33.61	19.54
IOL Chemicals & Pharmaceuticals Ltd ₹395.55(+3.25/0.83%)	395.55	+3.25	2,322.10	-0.40	13.44	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 14	Sep 14	Jun 14	Mar 14	Dec 13	Sep 13
Gross Sales	171.12	114.03	201.44	20.79	150.57	132.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	171.12	114.03	201.44	20.79	150.57	132.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	4.92	4.37	0.00	7.83	0.00	0.04
Total Income	176.03	118.40	201.44	28.63	150.56	132.04
Total Expenditure	165.90	108.43	191.41	22.12	129.99	115.17
PBIDT	10.14	9.97	10.03	6.51	20.57	16.87
Interest	8.85	8.68	8.69	10.29	12.67	8.31
PBDT	1.29	1.29	1.33	-3.78	7.90	8.56
Depreciation	1.26	1.26	1.25	5.04	5.15	5.15
Tax	0.01	0.01	0.03	-2.67	0.89	1.67
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.02	0.02	0.06	-6.15	1.86	1.74
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	-0.09
Adjusted Profit After Extra-ordinary item	0.02	0.02	0.06	-6.15	1.86	1.83

EPS (Unit Curr.)	0.00	0.00	0.02	-1.70	1.34	1.25
EPS (Adj) (Unit Curr.)	0.00	0.00	0.02	-1.70	1.34	1.25
Calculated EPS (Unit Curr.)	0.00	0.00	0.01	0.00	1.34	1.25
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	0.01	0.00	1.34	1.25
Calculated EPS (Ann.) (Unit Curr.)	0.01	0.01	0.05	0.00	5.35	5.00
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.01	0.01	0.05	0.00	5.35	5.00
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	105.26	53.37	53.37	31.66	13.89	13.89
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	105259442.00	50953468.00	50753468.00	28486875.00	10444037.00	10404210.00
Public Shareholding (% in Equity)	100.00	95.47	95.09	89.99	75.21	74.92

Pledged/Encumbered - No. of Shares	0.00	2297500.00	2297500.00	3168400.00	3105808.00	3145635.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	86.73	87.74	100.00	90.20	90.32
Pledged/Encumbered - % in Total Equity	0.00	3.93	4.30	10.01	22.36	22.65

Non Encumbered - No. of Shares	0.00	320900.00	320900.00	320900.00	337306.00	337306.00
Non Encumbered - % in Total Promoters Holding	0.00	13.27	12.26	10.13	9.80	9.68
Non Encumbered - % in Total Equity	0.00	0.60	0.61	1.01	2.43	2.43

PBIDTM(%)	5.93	8.74	4.98	31.31	13.66	12.78
PBDTM(%)	0.75	1.13	0.66	-18.18	5.25	6.48
PATM(%)	0.01	0.02	0.03	-29.58	1.24	1.32

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 14	Mar 13	Mar 12	Mar 11	Mar 10	Mar 09
SOURCES OF FUNDS :
Share Capital	31.66	13.89	13.89	7.58	5.78	4.95
Reserves Total	376.21	295.58	335.91	126.81	44.00	7.36
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	407.87	309.47	349.80	134.39	49.78	12.31
Secured Loans	215.99	179.76	193.95	123.35	49.59	31.41
Unsecured Loans	278.57	370.27	104.64	15.50	10.10	6.22
Total Debt	494.56	550.03	298.59	138.85	59.69	37.63
Total Liabilities	902.43	859.50	648.39	273.24	109.47	49.94
APPLICATION OF FUNDS :
Gross Block	248.82	248.55	233.72	74.56	48.55	13.95
Less : Accumulated Depreciation	60.53	40.09	19.87	4.21	1.62	0.75
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	188.29	208.46	213.85	70.35	46.93	13.20
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	179.01	164.09	144.24	46.68	4.20	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	212.78	2.40	0.78	0.05	0.05	0.05
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	185.53	166.49	137.52	82.37	36.04	15.34
Sundry Debtors	365.91	272.37	200.58	90.46	43.30	30.92
Cash and Bank	1.22	212.33	4.15	0.67	0.75	0.73
Loans and Advances	129.78	18.51	16.59	4.30	3.49	0.46
Total Current Assets	682.44	669.70	358.83	177.80	83.58	47.45
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	338.65	163.18	42.39	-3.89	16.43	7.24
Provisions	4.43	5.55	12.64	20.45	6.51	2.51
Total Current Liabilities	343.08	168.73	55.02	16.56	22.94	9.75
Net Current Assets	339.36	500.97	303.80	161.24	60.64	37.70
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	17.22	16.61	14.39	4.98	2.35	1.01
Net Deferred Tax	-17.22	-16.61	-14.39	-4.98	-2.35	-1.01
Total Assets	902.22	859.31	648.28	273.34	109.47	49.94
Contingent Liabilities	0.82	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Cash and Cash Equivalents at Beginning of the year	212.33	4.15	0.67	0.75	0.72
Net Cash from Operating Activities	134.66	39.67	-45.83	-45.81	0.54
Net Cash Used In Investing Activities	-225.57	-36.02	-255.77	-68.41	-38.75
Net Cash Used In Financing Activities	-120.20	204.54	305.08	114.14	38.24
Net Inc./Dec In Cash And Cash Equivalents	-211.11	208.19	3.48	-0.08	0.03
Cash And Cash Equivalents At End Of The Year	1.22	212.34	4.15	0.67	0.75

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

0.00%

FII Shareholding

2.20%

DII Shareholding

0.47%

Public Shareholding

97.33%

**Promoter pledged shareholding 0.00%

About Dr.Datsons Labs Ltd

Dr.Datsons Labs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 68.93 crores. It has reported a sales of Rs. 171.12 crores and a net profit of Rs. 0.02 crores for the quarter ended December 2018. The company management includes , Rajendra Kamat,Anjali Jadhav,Dinesh Surana (Dr.Datsons Labs Ltd) among others.

Chairman

Registered office

K-4/1 Additional MIDC,Dist Raigad,Mahad,Maharashtra,402309

FAX :

Background

Incorporation Year2006

Face Value₹10

Market Lot1

How to buy Dr.Datsons Labs shares on nse?

To buy Dr.Datsons Labs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Dr.Datsons Labs share price today?

The Dr.Datsons Labs shares price on nse is Rs.6.4 today.

What is the market cap of Dr.Datsons Labs shares on NSE ?

The company has a market capitalization of Rs.70.13Cr

What is the PE & PB ratio of Dr.Datsons Labs shares ?

PE is 0 and PB is 0.11

What is the 52 Week High and Low of Dr.Datsons Labs shares?

Dr.Datsons Labs stock price high: Rs.6.4 Dr.Datsons Labs stock price low: Rs.0